Skip to main content

Advertisement

SpringerLink
Log in

Highlights of the Annual Meeting of the European Association of Nuclear Medicine: Brussels 1995

The art of imaging the body

  • Review article
  • Published:
European Journal of Nuclear Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Britton K. Highlights of the Annual Meeting of the European Association of Nuclear Medicine, Lausanne 1993.Eur J Nucl Med 1994; 21: 159–169.

    PubMed  Google Scholar 

  2. Schillaci O, Scopinaro F, Mingazzini PL, Bergomi S, Danieli R, Manni C, Limiti MR, Pagan M, Virno F, Centi Colella A.99mTc-MIBI (M) in breast cancer (BC): correlation with node (n) status, angiogenesis (A) and Ki-67 (K) staining [abstract].Eur J Nucl Med 1995; 22: 726.

    Google Scholar 

  3. Palmedo H, Schomburg A, Grünwald F, Bender H, Mallmann P, Biersack HJ [abstract]. Mammoscintigraphy with Tc-99m MIBI in patients with suspicious breast nodules: a comparison of planar and SPECT imaging techniques [abstract].Eur J Nucl Med 1995; 22: 725.

    Google Scholar 

  4. Avril N, Jänicke F, Dose J, Ziegler S, Bense S, Zincke M, Römer W, Weber W, Herz M, Schwaiger M. Evaluation of axillary lymph node involvement in breast cancer patients using F-18 FDG PET [abstract].Eur J Nucl Med 1995; 22: 733.

    Google Scholar 

  5. Scheidhauer K, Scharl A, Pietrzyk U, Wagner R, Schomäcker K, Theissen P, Schicha H. Qualitative [F-18]FDG-PET in breast tumors [abstract].Eur J Nucl Med 1995; 22: 734.

    Google Scholar 

  6. Lietzenmayer R, Feine U, Hirnle P, Schmidt D, Müller-Schimpfle M, Kaiser W. Claussen CD, Müller-Schauenburg W. Whole body (WB) 18-FDG PET in primary and recurrent breast cancer: comparison with other imaging modalities and histology in 37 patients [abstract].Eur J Nucl Med 1995; 22: 734.

    Google Scholar 

  7. Adalet I, Demirkol O, Müslümanoglu M, Koçak M, Bozfakioglu Y, Cantez S. Tc-99m tetrofosmin scintigraphy in the evaluation of palpable breast masses: preliminary results [abstract].Eur J Nucl Med 1995; 22: 742.

    Google Scholar 

  8. Tiling R. Sommer H, Pechmann M, Kress K, Meyer G, Pfluger T, Tatsch K, Hahn K. Detection of carcinomas in mammographic dense breasts and mastopathies: GD-enhanced MRI versus semiquantitative Tc-99m sestamibi [abstract].Eur J Nucl Med 1995; 22: 726.

    Google Scholar 

  9. Rijks LJM, de Bruin K, Bakker PJM, Veenhof CHN, Janssen AGM, van Royen EA. First results with the estrogen receptor radioligand Z-[I-123]mive in metastatic breast cancer patients [abstract].Eur J Nucl Med 1995; 22: 743.

    Google Scholar 

  10. Meller-Rehbein B, Schomaecker K, Scheidhauer K, Scharl A, Baehre M, Schicha H, Richter E.123I-diethylstilbestrol diphosphate (DSEP) — biokinetics of a potential tracer for estrogen receptor-imaging [abstract].Eur J Nucl Med 1995; 22: 743.

    Google Scholar 

  11. Hoefnagel CA, Valdés Olmos RA, Rankin EM, Israëls SP. Melanoma detection using indium-111 pentetreotide [abstract].Eur J Nucl Med 1995; 22: 753.

    Google Scholar 

  12. Steinert H, Huch Böni RA, Böni R, Buck A, Burger C, Berthold T, Burg G, Von Schulthess GK. Metastatic melanoma: staging with whole body FDG-PET and first experience with image fusion of PET and spiral CT [abstract].Eur J Nucl Med 1995; 22: 754.

    Google Scholar 

  13. Wöhrle H. Feine U, Geiger L, Blessing C, Laniado M, Friese S, Lietzenmayer R, Fierlbeck G, Müller-Schauenburg W. Whole body 18-FDG PET in 46 patients with recurrent malignant melanomas: a comparison versus CT and MRI [abstract].Eur J Nucl Med 1995; 22: 753.

    Google Scholar 

  14. Everaert H. Flamen P, Franken PR, Bossuyt A. IDAB: a new tracer for scintigraphic visualisation of malignant melanoma [abstract].Eur J Nucl Med 1995; 22: 753.

    Google Scholar 

  15. Chiti A, Grasselli G, Maffioli L, Gasparini M, Infante M, Bombardieri E. Assessment of mediastinal involvement in lung cancer with [99mTc]-sestamibi SPET [abstract].Eur J Nucl Med 1995; 22: 774.

    Google Scholar 

  16. Baum R, Rust M, Strassmann G, Berkefeld J, Wagner R, Hertela A, Caspary W, Höer G. Whole body positron emission tomography (PET) with 2-[18F]-fluoro-2-deoxy-d-glucose for preoperative staging of lung cancer: influence on patients' management [abstract].Eur J Nucl Med 1995; 22: 775.

    Google Scholar 

  17. Steinert H, Hauser M, Allemann F, Berthold T, Weder W, Von Schulthess GK. Non-small cell lung cancer: staging by whole body FDG-PET, CT and surgical correlation [abstract].Eur J Nucl Med 1995; 22: 775.

    Google Scholar 

  18. Wunderlich G, Schmidt D, Langen KJ, Ziemons K, Kiwit JCW, Stöcklin G, Müller-Gärtner HW. Evaluation of chemotherapy in gliomas by I-123-α-methyltyrosine SPECT: first results [abstract].Eur J Nucl Med 1995; 22: 796.

    Google Scholar 

  19. De Vadder N, Mortelmans L, Schiepers C, Menten J, Van Loon J, Plets C, De Roo M. Initial clinical experience with F-18 FDG PET in the follow-up of treated primary brain neoplasms [abstract].Eur J Nucl Med 1995; 22: 796.

    Google Scholar 

  20. Müller SP, Jeske J, Geworski L, Kappeler C, Lahmer D, Tamulevicius P, Stolke D, Streffer C, Reiners C, Sciuk J. Comparison of F-18 FDG PET in brain tumor patients with in-vitro analysis of glucose metabolites in biopsies [abstract].Eur J Nucl Med 1995; 22: 796.

    Google Scholar 

  21. Raderer M, Becherer A, Kurtaran A, Li S, Leimer M, Angelberger P, Kletter K, Kornek G, Weinlaender G, Scheithauer W, Virgolini I. Comparison of123I-VIP receptor scanning and tag-72 antigen scanning (oncoscint) in patients with gastrointestinal cancer [abstract].Eur J Nucl Med 1995; 22: 815.

    Google Scholar 

  22. Steffens MG, Oosterwijk E, Boerman OC, Oosterhof GON, Koenders E, Debruyne FJM, Corstens FHM. Renal cell carcinoma targeting with I-131 labeled chimeric G250 monoclonal antibody: a phase I study [abstract].Eur J Nucl Med 1995; 22: 819.

    Google Scholar 

  23. Oosterwijk E, Bander N, Divgi C, Welt S, Wakka J, Finn R, Carswell E, Larson S, Warnaar S, Fleuren GJ, Oettgen H, Old L. Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.J Clin Oncol 1993; 11: 738–750.

    PubMed  Google Scholar 

  24. Buchegger F, Bischof Delaloye A, Gillet M, Doenz F, Achtari C, Vogel CA, Mach JP, Delaloye B. Biokinetics of anti-cea F(ab′)2 simultaneously injected into the hepatic artery and a peripheral vein in patients with liver metastases of colorectal carcinoma [abstract].Eur J Nucl Med 1995; 22: 822.

    Google Scholar 

  25. Shulkin BL, Wieland DM, Shapiro B, Sisson JC. PET studies of pheochromocytomas with C-11 epinephrine [abstract].Eur J Nucl Med 1995; 22: 836.

    Google Scholar 

  26. Béhé M, Mäcke HR. New somatostatin analogues labelled with technetium 99-m [abstract].Eur J Nucl Med 1995; 22: 791.

    Google Scholar 

  27. Vallabhajosula S, Moyer BR, Lister-James J, McBride BJ, Dean RT. TechtideTM Tc-99m-P829: A high-affinity somatostatin receptor-binding peptide exhibiting low GI uptake [abstract].Eur J Nucl Med 1995; 22: 791.

    Google Scholar 

  28. Schomäcker K, Wellner U, Gabruk-Szostak B, Gerard H, Steinbach J, Füchtner F, Schicha H. Properties of I-131 therapy capsules affect the radioiodine-biokinetics [abstract].Eur J Nucl Med 1995; 22: 798.

    Google Scholar 

  29. Barrington SF, Kettle AG, Mountford PJ, Thomson WH, Batchelor S, Burrell DN, O'Doherty MJ, Harding LK. Radiation exposure of patients' children at home post I-131 administration [abstract].Eur J Nucl Med 1995; 22: 798.

    Google Scholar 

  30. De Klerk JMH, van het Schip AD, Zonnenberg BA, van Dijk A, Blijham GH, van Rijk PP. Phase 1 study of Re-186-HEDP in patients with bone metastases originating from breast cancer [abstract].Eur J Nucl Med 1995; 22: 807.

    Google Scholar 

  31. Limouris GS, Manetou A, Shukla SK, Stauraka A, Vlahos L. Combined89Sr-chloride/186Re-HEDP application in bone metastases [abstract].Eur J Nucl Med 1995; 22: 808.

    Google Scholar 

  32. Clunie GPR, Ell PJ. European radiation synovectomy practice 1991–3 [abstract].Eur J Nucl Med 1995; 22: 829.

    Google Scholar 

  33. Behr TM, Sharkey RM, Juweid ME, Aninipot R, Mattes MJ, Stein R, Blumenthal RD, Griffiths GL, Goldenberg DM. Residualizing radiometals (indium, yttrium) versus released (iodine) isotopes in radioimmunodetection and therapy with internalizing antibodies [abstract].Eur J Nucl Med 1995; 22: 765.

    Google Scholar 

  34. De Jong M, Breeman WAP, Bernard HF, Rolleman EJ, Hofland LJ, Visser TJ, Setyono-Han B, Bakker WH, van der Pluijm ME, Krenning EP. Evaluation in vitro and in rats of Tb-161-DTPA-Octreotide, a somatostatin analogue with potential for intraoperative scanning and radiotherapy [abstract].Eur J Nucl Med 1995; 22: 832.

    Google Scholar 

  35. Kostakoğlu L, Caner B, Uğur, Sayek I, Ruacan Ş, Elahi N, Aras T, Bekdik C. Clinical validation of the influence of MDR expression on Tc-99m-sestamibi uptake [abstract].Eur J Nucl Med 1995; 22: 734.

    Google Scholar 

  36. Fantone J, Ward P. Mechanism of inflammation. In: Rubin E, Farber JL, eds.Pathology, 1st edn. Philadelphia: Lippincott, 1988.

    Google Scholar 

  37. Van der Laken C, Boerman O, Oyen W, Van de Ven M, Claessens R, Van der Meer J, Corstens F. Comparison of radiolabeled human recombinant interleukin-1 with its receptor antagonist in a model of infection [abstract].Eur J Nucl Med 1995; 22: 729.

    Google Scholar 

  38. Chianelli M, Signore A, Biassoni L, Sobnack R, Procaccini E, Ronga G, Plowman PN, Grossman A, Britton KE, Mather SJ. In vivo imaging of autoimmunity by 99m-Tc-interleukin-2 [abstract].Eur J Nucl Med 1995; 22: 780.

    Google Scholar 

  39. Signore A. Picarelli A, Maiuri L, Ferretti E, Chianelli M, Barone R, Procaccini E, Greco M, Ronga G, Pozzilli P.123I-IL2 for in vivo detection of activated lymphocytes: a scintigraphic and histological study in coeliac patients [abstract].Eur J Nucl Med 1995; 22: 794.

    Google Scholar 

  40. Signore A, Biancone L, Ferretti E, Chianelli M, Barone R, Procaccini E, Ronga G, Pozzilli P, Pallone F.123I-labelled interleukin-2 in Crohn's disease: assessment of activity state and therapy follow-up [abstract].Eur J Nucl Med 1995; 22: 795.

    Google Scholar 

  41. Becker W, Repp R, Hansen HJ, Goldenberg DM, Wolf F. Binding characteristics and kinetics of a new Tc-99m-antigranulocyte FAB′-fragment (LeukoscanTM) [abstract].Eur J Nucl Med 1995; 22: 728.

    Google Scholar 

  42. Harwood SJ, Hakki S, Camblin JG, Morrissey M, Laven DL, Webster WB, Carroll RG. Tc-99m IMMU-MN3 (LeukoscanTM) In-111 WBC, and Tc-99m MDP bone scans: diagnostic accuracy in orthopedic infections [abstract].Eur J Nucl Med 1995; 22: 736.

    Google Scholar 

  43. Lazzeri E, Molea N, Marchetti S, Manca M, Faldini A, Bianchi R, Mariani G. Scintigraphic imaging of infection-inflammation in orthopedic patients by the avidin-111In-biotin system [abstract].Eur J Nucl Med 1995; 22: 736.

    Google Scholar 

  44. Vinjamuri S, Hall AV, Solanki KK, O'Shaughnessy EM, Bomanji JB, Siraj Q, Das SS, Britton KE. Tc-99m infection, Tc-I, a bacterial specific infection imaging agent [abstract].Eur J Nucl Med 1995; 22: 916.

    Google Scholar 

  45. Bakker-Woudenberg I, Lokerse A, Ten Kate M, Mouton J, Woodle M, Storm G. Liposomes with prolonged blood circulation and selective localization inKlebsiella pneumoniae-infected lung tissue.J Infect Dis 1993; 168: 164–171.

    PubMed  Google Scholar 

  46. Boerman OC, Oyen WJG, Storm G, Koenders EB, van Bloois L, Crommelin DJA, van der Meer JWM, Claessens RAMJ, Corstens FHM. Imaging experimental focal infection with In-111 and Tc-99m-labeled stealth lipsomes [abstract].Eur J Nucl Med 1995; 22: 728.

    Google Scholar 

  47. Asenbaum S, Brücke T, Pirker W, Wöber C, Podreka I. [123I]-β-CIT and SPET in the diagnosis of movement disorders [abstract].Eur J Nucl Med 1995; 22: 812.

    Google Scholar 

  48. Halldin C, Farde L, Lundkvist C, Nakashima Y, Ginovart N, Karlsson P, Swahn CG, Neumeyer JL, Milius RA, Wang S. Quantitation of dopamine transporters in vivo by PET using a new radioligand, [C-11]β-CIT-FP [abstract].Eur J Nucl Med 1995; 22: 833.

    Google Scholar 

  49. Bergström K, Halldin C, Kuikka J, Lundkvist C, Åkerman K, Swahn C, Hiltunen J, Länsimies E, Neumeyer J, Farde L. Importance of metabolite studies of I-123 and C-11 labelled β-CIT and analogues with respect to the quantitation of dopamine transporter [abstract].Eur J Nucl Med 1995; 22: 824.

    Google Scholar 

  50. Vermeulen RJ, Booij J, Tissingh G, Janssen AGM, Speelman JD, Wolters EC, van Royen EC. Visualization of dopamine reuptake sites with [123-I]β-CIT SPET in Parkinson's disease and multiple system atrophy [abstract].Eur J Nucl Med 1995; 22: 812.

    Google Scholar 

  51. Brücke T, Asenbaum S, Pirker W, Pozzera A, Wenger S, Wöber C, Müller C, Angelberg P, Podreka I. Quantification of the dopaminergic nerve cell loss in Parkinson's disease with [I-123]-β-CIT and SPECT [abstract].Eur J Nucl Med 1995; 22: 812.

    Google Scholar 

  52. Kuikka J, Tilhonen J, Bergström K, Hakola P, Karhu J, Ryynanen O, Fohr J, Lansimies E. Altered striatal dopamine transporter density in habitually violent and non-violent alcoholics [abstract].Eur J Nucl Med 1995; 22: 823.

    Google Scholar 

  53. Loch C, Halldin C, Hall H, Bourguignon M, Syrota A, Mazière M, Farde L, Mazière B. In vivo and in vitro visualization of dopamine D2 extrastriatal binding of I-123 epidepride in the human brain [abstract].Eur J Nucl Med 1995; 22: 824.

    Google Scholar 

  54. Pirker W, Riedl M, Luger A, Csech T, Rössler K, Asenbaum S, Angelberg P, Deecke L, Podreka I, Brücke T. SPECT imaging of dopamine D2 receptors in pituitary adenomas using [123I]-epidepride [abstract].Eur J Nucl Med 1995; 22: 833.

    Google Scholar 

  55. Pike V, McCarron J, Hume S, Ashwordt S, Opacka-Juffry J, Lammerstma A, Poole K, Malizia A, Bench C, Grasby P, Cliffe IA, Fletcher A. Imaging of 5-HT1A receptors in human brain using [C-11]way-100635 and PET [abstract].Eur J Nucl Med 1995; 22: 833.

    Google Scholar 

  56. Vanhove C, Demonceau G, De Vuyst J, De Rick G, Coleart H, Monte C. A 120 patient normal database for brain SPECT [abstract].Eur J Nucl Med 1995; 22: 842.

    Google Scholar 

  57. Panoutsopoulos G, Petrou A, Skiadas M, Batsakis C, Papanagnou G, Bobolakis K, Savari E, Christacopoulou I. Combined intravenous dipyridamole and bicycle exercise test for thallium SPECT imaging: safety and clinical value [abstract].Eur J Nucl Med 1995; 22: 744.

    Google Scholar 

  58. Faraggi M, Dahan M, Sarda L, Lebtahi R, Legallicier B, Himbert D, François D, Mignon F, Le Guludec D. Asymptomatic patients with chronic dialysis therapy: accuracy of stress thallium-SPECT for the diagnosis of coronary artery diseaese [abstract].Eur J Nucl Med 1995; 22: 734.

    Google Scholar 

  59. Milan E, Terzi A, Gioia G, Russell J, Vaccari A, Cassel D, Facchetti L, Iskandrian AS, Giubbini R. Evaluation of single stress99mTc sestamibi SPET to predict normal results [abstract].Eur J Nucl Med 1995; 22: 757.

    Google Scholar 

  60. Schultz G, vom Dahl J, Banneitz L, Kleinhans E. Buell U. Depth of a myocardial perfusion defect parallels β-oxidation but not glucose metabolism [abstract].Eur J Nucl Med 1995; 22: 776.

    Google Scholar 

  61. Carrió L, Estorch M. López-Pousa J, Berná L, Torres G. Influence of age and gender on myocardial 123I-MIBG uptake [abstract].Eur J Nucl Med 1995; 22: 804.

    Google Scholar 

  62. Rodriques M, Karanikas G, Rogatti W, Peskar B, Sinzinger H. Radiolabeled lipoprotein(a) in an experimental model of atherogenesis and preliminary studies in humans [abstract].Eur J Nucl Med 1995; 22: 817.

    Google Scholar 

  63. Theissen P, Emmel M. Dietlein M, Scheidhauer K, Schickendantz S, Menniken U, Schicha H. Perfusion scintigraphy of the lungs in children with congenital cardio-pulmonary disease [abstract].Eur J Nucl Med 1995; 22: 751.

    Google Scholar 

  64. Oyen WJG, van Oort AM, Tanke RB, van Mill GJ, Aengevaeren WRM, Corstens FHM. Quantitative assessment of pulmonary perfusion after endovascular stenting of pulmonary artery branch stenosis in corrected tetralogy of Fallot [abstract].Eur J Nucl Med 1995; 22: 751.

    Google Scholar 

  65. Virgolini I, Kurtaran A, Leimer M, Agis H, Angelberger P, Kletter K, Valent P, Linkesch W, Eichler HG. 123I-interferon gamma 1b (IFNγ): inhalation scintigraphy in healthy volunteers [abstract].Eur J Nucl Med 1995; 22: 732.

    Google Scholar 

  66. Stegen M, Wanet P, Metello L, Rubinstein M. Improving sensitivity of thyroid scintigraphy using pinhole SPECT [abstract].Eur J Nucl Med 1995; 22: 745.

    Google Scholar 

  67. Wanet P, Sand A, Abramovici J. High resolution thyroid pinhole SPECT: clinical evaluation after one year experience [abstract].Eur J Nucl Med 1995; 22: 745.

    Google Scholar 

  68. Maurea S, Klain M, Lastoria S, Grivet Fojaja MR, Varrella P, Acampa W, Colao A, Lombardi G, Salvatore M. Doublephase technetium-99m MIBI imaging in the evaluation of patients with thyroid adenomas [abstract].Eur J Nucl Med 1995; 22: 746.

    Google Scholar 

  69. Bohuslavizki K, Kerscher A, Fleiner B, Brenner W, Sippel C, Wolf H, Tinnemeyer S, Schramm M, Clausen M, Hense E. Impact of bone scanning on preoperative decision-making in hemimandibular elongation [abstract].Eur J Nucl Med 1995; 22: 760.

    Google Scholar 

  70. Becker W, Döninghaus K, Munzer B, Wildt L, Wolf F. Hysterosalpingoscintigraphy shows functional fallopian tube patency independent from the anatomincal situation [abstract].Eur J Nucl Med 1995; 22: 790.

    Google Scholar 

  71. Chen E, MacIntyre W, Go R, Brunken R, Khandekar S. Differences in imaging characteristics of PET and 511 keV SPECT: implications in FDG myocardial viability studies [abstract].Eur J Nucl Med 1995; 22: 809.

    Google Scholar 

  72. Schaefer A, Reiche W, Kirsch CM, Piepgras U. Single photon emission computed tomography of brain tumours using 18 fluorodeoxyglucose: methodical aspects and first results [abstract].Eur J Nucl Med 1995; 22: 809.

    Google Scholar 

  73. Wagner HN. A new era of certainty.J Nucl Med 1995; 36: 13N–28N.

    Google Scholar 

  74. Paans A, Nickles R, De Graaf E, Vaalburg W, Reiffers S, Steenhoek A, Woldring M. A dual head anger camera system for the imaging of positron-emitting radionuclides.Int. J Nucl Med Biol 1978; 5: 266–271.

    PubMed  Google Scholar 

  75. Paans A, Vaalburg W, Woldring M. A rotating double-headed positron camera.J Nucl Med 1985; 26: 1466–1471.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, University Hospital Nijmegen, Nijmegen, The Netherlands

    Frans H. M. Corstens

Authors
  1. Frans H. M. Corstens
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Corstens, F.H.M. Highlights of the Annual Meeting of the European Association of Nuclear Medicine: Brussels 1995. Eur J Nucl Med 23, 75–90 (1996). https://doi.org/10.1007/BF01736994

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01736994

Keywords

Search

Navigation